YO NEURONAL ANTIBODY FOR PARANEOPLASTIC SYNDROMES / SERUM

image not found

NABL Cap Accredited   
The Yo Neuronal Antibody test helps detect antibodies associated with paraneoplastic neurological syndromes, particularly in individuals with suspected underlying malignancies. Metropolis Healthcare analyses serum samples using sensitive immunological methods to support accurate diagnosis. This test aids in identifying immune-mediated neuronal damage and assists clinicians in early evaluation of paraneoplastic disorders. It is especially useful when neurological symptoms suggest an autoimmune response linked to cancer 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,528.00

Sample Type: SERUM

Fasting Not Required


Notes: Y0005

Frequently Asked Questions (FAQ's):

What does the Yo Neuronal Antibody test include?
This test detects Yo (PCA-1) antibodies in serum, analyzed using advanced immunoassay techniques at Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-sensitivity laboratory methods to identify specific neuronal antibodies associated with paraneoplastic syndromes.

Who should take this test?
Individuals with unexplained neurological symptoms, suspected paraneoplastic syndromes, or clinicians investigating autoimmune neurological diseases may be advised to take this test.

Why is the Yo Neuronal Antibody test important?
Detecting Yo antibodies helps identify immune-mediated disorders often linked to underlying cancers such as breast or ovarian malignancies.

What sample is required for this test?
A serum sample is needed, which can be provided at any Metropolis Healthcare blood collection center.

Is fasting required for this test?
No, fasting is not required for Yo Neuronal Antibody testing at Metropolis Healthcare.

How soon can I expect the results?
Metropolis Healthcare typically provides results within the standard turnaround time for specialized immunology tests.

How does this test help in clinical decision-making?

A positive result supports early diagnosis and helps clinicians investigate potential underlying malignancies and initiate timely management 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab